Aristotle Capital Boston, LLC released its second quarter 2025 investor letter, reporting a 3.25% return net of fees, underperforming the Russell 2000 Index’s 8.50% total return. Guardian Pharmacy Services, Inc. (NYSE:GRDN) was highlighted in the letter, with a one-month return of 0.10% and YTD gain of 0.35%. The stock closed at $20.33 per share on July 22, 2025, with a market cap of $1.287 billion.

Aristotle Capital Small Cap Equity Strategy praised Guardian Pharmacy Services, Inc. (NYSE:GRDN) as a leading provider of pharmacy services to long-term care facilities in the U.S. They believe the company’s technology-driven service offering positions it well to capitalize on the aging U.S. population trend and grow faster than the overall market.

Guardian Pharmacy Services, Inc. (NYSE:GRDN) is not among the 30 Most Popular Stocks Among Hedge Funds, with only 9 hedge fund portfolios holding it at the end of the first quarter. While recognizing its investment potential, the article suggests that certain AI stocks offer greater upside potential and lower downside risk. For more information on an undervalued AI stock with significant growth potential, check out their free report on the best short-term AI stock.

Read more at Yahoo Finance: Should You Consider Adding Guardian Pharmacy Services (GRDN) to Your Portfolio?